UltraTech Cement Ltd
NSE:ULTRACEMCO
UltraTech Cement Ltd
NSE:ULTRACEMCO
Price:
11 472.6
INR
0.1%
Market Closed
Market Cap:
3.3T
INR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
ULTRACEMCO Alert
UltraTech Cement Ltd
11472.6
+11.65 (+0.1%)
| 52 Week Range |
9 390
12 082.35
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
UltraTech Cement Ltd
Balance Sheet
Balance Sheet Decomposition
UltraTech Cement Ltd
UltraTech Cement Ltd
| Current Assets | 237.9B |
| Cash & Short-Term Investments | 84.3B |
| Receivables | 43.7B |
| Other Current Assets | 109.9B |
| Non-Current Assets | 838.2B |
| Long-Term Investments | 56.5B |
| PP&E | 618.3B |
| Intangibles | 126.2B |
| Other Non-Current Assets | 37.2B |
| Current Liabilities | 283.9B |
| Accounts Payable | 78.1B |
| Other Current Liabilities | 205.9B |
| Non-Current Liabilities | 178.5B |
| Long-Term Debt | 86.5B |
| Other Non-Current Liabilities | 92B |
Balance Sheet
UltraTech Cement Ltd
UltraTech Cement Ltd
Currency: INR
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
820
|
902
|
588
|
772
|
7 396
|
5 392
|
1 772
|
1 205
|
3 704
|
7 832
|
|
| Cash |
820
|
902
|
588
|
772
|
4 412
|
1 465
|
1 772
|
1 205
|
3 704
|
5 536
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
2 984
|
3 927
|
0
|
0
|
0
|
2 296
|
|
| Short-Term Investments |
29 273
|
25 347
|
54 341
|
39 556
|
25 628
|
53 046
|
125 265
|
50 268
|
64 394
|
55 225
|
|
| Total Receivables |
24 706
|
27 311
|
25 935
|
33 724
|
30 223
|
24 361
|
53 866
|
53 213
|
58 353
|
65 461
|
|
| Accounts Receivables |
16 664
|
19 364
|
17 764
|
22 391
|
27 870
|
22 383
|
25 757
|
30 648
|
38 500
|
43 889
|
|
| Other Receivables |
8 042
|
7 947
|
8 171
|
11 333
|
2 353
|
1 978
|
28 109
|
22 565
|
19 853
|
21 572
|
|
| Inventory |
31 606
|
27 542
|
28 689
|
37 233
|
40 990
|
41 483
|
45 526
|
64 279
|
74 193
|
92 003
|
|
| Other Current Assets |
1 922
|
24 237
|
23 693
|
3 328
|
25 305
|
26 212
|
14 073
|
5 929
|
6 785
|
13 360
|
|
| Total Current Assets |
88 327
|
105 339
|
133 246
|
114 613
|
129 542
|
150 494
|
240 503
|
174 895
|
207 429
|
231 584
|
|
| PP&E Net |
244 616
|
253 498
|
253 972
|
371 479
|
457 919
|
460 224
|
453 063
|
485 480
|
517 056
|
578 251
|
|
| PP&E Gross |
0
|
253 498
|
253 972
|
371 479
|
0
|
0
|
453 063
|
485 480
|
517 056
|
578 251
|
|
| Accumulated Depreciation |
0
|
12 660
|
25 317
|
42 335
|
0
|
0
|
112 170
|
136 382
|
163 052
|
191 333
|
|
| Intangible Assets |
2 124
|
3 224
|
3 435
|
30 423
|
57 827
|
56 271
|
55 721
|
54 740
|
55 846
|
55 182
|
|
| Goodwill |
10 531
|
11 062
|
10 851
|
10 363
|
62 233
|
62 525
|
62 199
|
62 502
|
63 293
|
63 455
|
|
| Note Receivable |
8 198
|
6 201
|
4 709
|
23 730
|
12 839
|
15 115
|
31 873
|
35 626
|
48 935
|
44 330
|
|
| Long-Term Investments |
27 149
|
30 127
|
13 547
|
15 175
|
16 790
|
20 848
|
18 388
|
24 824
|
19 033
|
31 903
|
|
| Other Long-Term Assets |
2 733
|
2 582
|
2 427
|
5 722
|
28 224
|
28 286
|
89
|
210
|
2 279
|
3 316
|
|
| Other Assets |
10 531
|
11 062
|
10 851
|
10 363
|
62 233
|
62 525
|
62 199
|
62 502
|
63 293
|
63 455
|
|
| Total Assets |
383 678
N/A
|
412 033
+7%
|
422 187
+2%
|
571 505
+35%
|
765 374
+34%
|
793 763
+4%
|
861 835
+9%
|
838 278
-3%
|
913 870
+9%
|
1 008 020
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
17 009
|
17 173
|
18 573
|
23 849
|
31 597
|
35 043
|
46 993
|
58 628
|
72 093
|
84 783
|
|
| Accrued Liabilities |
1 350
|
1 172
|
1 440
|
1 669
|
0
|
0
|
4 504
|
1 383
|
5 044
|
5 379
|
|
| Short-Term Debt |
25 639
|
24 758
|
10 792
|
27 634
|
36 684
|
39 851
|
42 351
|
48 998
|
34 773
|
44 412
|
|
| Current Portion of Long-Term Debt |
22 429
|
32 436
|
10 245
|
8 533
|
10 182
|
15 453
|
28 168
|
7 462
|
12 134
|
7 118
|
|
| Other Current Liabilities |
41 339
|
40 644
|
42 242
|
53 469
|
76 869
|
76 352
|
83 901
|
85 081
|
110 274
|
127 367
|
|
| Total Current Liabilities |
107 766
|
116 182
|
83 292
|
115 154
|
155 333
|
166 699
|
205 917
|
201 552
|
234 318
|
269 060
|
|
| Long-Term Debt |
53 798
|
48 966
|
63 708
|
158 635
|
206 504
|
184 234
|
146 675
|
62 812
|
63 671
|
62 499
|
|
| Deferred Income Tax |
21 325
|
24 411
|
27 824
|
31 827
|
64 114
|
49 120
|
60 407
|
60 332
|
62 601
|
64 478
|
|
| Minority Interest |
182
|
155
|
97
|
160
|
122
|
75
|
57
|
31
|
556
|
559
|
|
| Other Liabilities |
3 413
|
2 863
|
3 349
|
1 917
|
1 796
|
2 480
|
7 032
|
9 260
|
9 478
|
9 150
|
|
| Total Liabilities |
186 484
N/A
|
192 577
+3%
|
178 270
-7%
|
307 694
+73%
|
427 868
+39%
|
402 608
-6%
|
420 088
+4%
|
333 925
-21%
|
370 624
+11%
|
405 745
+9%
|
|
| Equity | |||||||||||
| Common Stock |
2 744
|
2 744
|
2 745
|
2 746
|
2 746
|
2 886
|
2 887
|
2 887
|
2 887
|
2 887
|
|
| Retained Earnings |
193 746
|
215 689
|
239 716
|
259 454
|
280 877
|
388 269
|
382 826
|
444 821
|
484 026
|
542 379
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
53 884
|
0
|
54 697
|
54 771
|
54 844
|
54 874
|
|
| Other Equity |
704
|
1 023
|
1 455
|
1 611
|
0
|
0
|
1 337
|
1 874
|
1 488
|
2 136
|
|
| Total Equity |
197 194
N/A
|
219 456
+11%
|
243 916
+11%
|
263 812
+8%
|
337 507
+28%
|
391 155
+16%
|
441 747
+13%
|
504 353
+14%
|
543 245
+8%
|
602 275
+11%
|
|
| Total Liabilities & Equity |
383 678
N/A
|
412 033
+7%
|
422 187
+2%
|
571 505
+35%
|
765 374
+34%
|
793 763
+4%
|
861 835
+9%
|
838 278
-3%
|
913 870
+9%
|
1 008 020
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
274
|
274
|
275
|
275
|
275
|
289
|
289
|
289
|
289
|
289
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
